Covered recipient · General Payments record
CANDACE SCHAEFER SANDERS
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$1,914.42
- Reported across 32 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,066.83 | 14 |
| Travel and Lodging | $311.60 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NEUROPACE, INC. | $793.76 | 4 |
| UCB, Inc. | $168.19 | 4 |
| JAZZ PHARMACEUTICALS INC. | $163.70 | 2 |
| Marinus Pharmaceuticals, Inc. | $147.61 | 1 |
| SK Life Science, Inc. | $60.49 | 2 |
| Medtronic, Inc. | $25.23 | 1 |
| LivaNova USA, Inc. | $19.45 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $137.21 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150204144 | CMS |
| JAZZ PHARMACEUTICALS INC. | $26.49 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150204142 | CMS |
| LivaNova USA, Inc. | $19.45 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152789837 | CMS |
| Marinus Pharmaceuticals, Inc. | $147.61 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141324398 | CMS |
| Medtronic, Inc. | $25.23 | 11/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117108862 | CMS |
| NEUROPACE, INC. | $115.06 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153274232 | CMS |
| NEUROPACE, INC. | $311.60 | 11/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1153274164 | CMS |
| NEUROPACE, INC. | $345.82 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153274172 | CMS |
| NEUROPACE, INC. | $21.28 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153274238 | CMS |
| SK Life Science, Inc. | $30.41 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154124291 | CMS |
| SK Life Science, Inc. | $30.08 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154124313 | CMS |
| UCB, Inc. | $37.77 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143124684 | CMS |
| UCB, Inc. | $48.50 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143124688 | CMS |
| UCB, Inc. | $41.02 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143124692 | CMS |
| UCB, Inc. | $40.90 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143124697 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.